Regulation of human apolipoprotein A-I gene expression by equine estrogens

Regulation of human apolipoprotein A-I gene expression by equine estrogens

Estrogen replacement therapies, such as conjugated equine estrogen (CEE, Premarin®), reduce the risk of coronary heart disease among postmenopausal women. In the present study, a HepG2 stable cell line (HepG2/S) that harbors a luciferase reporter gene cassette with the human apolipoprotein A-I (apoA...

Full description

Bibliographic Details
Main Authors:	Xia Zhang, Jei-Jun Jiao, Bhagu R. Bhavnani, Shui-Pang Tam
Format:	Article
Language:	English
Published:	Elsevier 2001-11-01
Series:	Journal of Lipid Research
Subjects:	apolipoprotein A-I estrogen replacement therapy gene regulation HDL
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520315054

Similar Items

Association of human apolipoprotein E with lipoproteins secreted by transfected McA RH7777 cells
by: Catherine A. Reardon, et al.
Published: (1998-07-01)

Cholesterol–sphingomyelin interaction in membrane and apolipoprotein-mediated cellular cholesterol efflux
by: Jin-ichi Ito, et al.
Published: (2000-06-01)

17β-estradiol regulates the expression of apolipoprotein M through estrogen receptor α-specific binding motif in its promoter
by: Jiang Wei, et al.
Published: (2017-03-01)

Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome
by: Lagu He, et al.
Published: (2017-09-01)

Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
by: Monique F. M. Santana, et al.
Published: (2020-09-01)

Evaluating the relation between serum apolipoprotein B (apo B), apolipoprotein A (apo A) and apo B/apo A ratio with diabetic retinopathy in a sample of type 2 Egyptian diabetic patient
by: Salwa Seddik Hosny, et al.
Published: (2023-08-01)

Apolipoprotein E-containing HDL decreases caspase-dependent apoptosis of memory regulatory T lymphocytes
by: Laura Atehortua, et al.
Published: (2023-09-01)

Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies1[S]
by: Jere P. Segrest, et al.
Published: (2013-10-01)

Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
by: Anna Wolska, et al.
Published: (2021-03-01)

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids
by: Mohamad Navab, et al.
Published: (2009-08-01)

HDL proteome and apolipoproteins concentrations in severe ICU COVID-19 patients
by: Floran Begue, et al.
Published: (2025-01-01)

Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells
by: John K. Bielicki, et al.
Published: (1999-01-01)

Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1
by: Karen Y.Y. Fung, et al.
Published: (2024-04-01)

Potential role of the interaction between equine estrogens, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in the prevention of coronary heart and neurodegenerative diseases in postmenopausal women
by: Gerulath Alan, et al.
Published: (2003-06-01)

Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?
by: Nicolas Vuilleumier, et al.
Published: (2013-05-01)

ESR1 polymorphism is associated with plasma lipid and apolipoprotein levels in Caucasians of the Rochester Family Heart Study*s⃞
by: Kathy L.E. Klos, et al.
Published: (2008-08-01)

Efficacy and Safety of High-Density Lipoprotein/Apolipoprotein A1 Replacement Therapy in Humans and Mice With Atherosclerosis: A Systematic Review and Meta-Analysis
by: Ayiguli Abudukeremu, et al.
Published: (2021-08-01)

Apolipoprotein A-II, a Player in Multiple Processes and Diseases
by: Gabriela Florea, et al.
Published: (2022-07-01)

Apolipoprotein E3-mediated cellular uptake of reconstituted high-density lipoprotein bearing core 3, 10, or 17 nm hydrophobic gold nanoparticles
by: Chuang ST, et al.
Published: (2017-11-01)

Association of polymorphism apolipoprotein A1 with the lipid profile serum
by: E. V. Schakhtschneider, et al.
Published: (2010-12-01)

Apolipoprotein E particle size is increased in Alzheimer's disease
by: Thomas J. Nelson, et al.
Published: (2019-12-01)

Apolipoprotein and lipid abnormalities in chronic liver failure
by: A.C. Spósito, et al.
Published: (1997-11-01)

Admission levels of high-density lipoprotein and apolipoprotein A-1 are associated with the neurologic outcome in patients with out-of-hospital cardiac arrest
by: Yong Soo Son, et al.
Published: (2017-12-01)

The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy
by: Andrea Iorga, et al.
Published: (2017-10-01)

Apolipoprotein A-I: structure–function relationships
by: Philippe G. Frank, et al.
Published: (2000-06-01)

Preparative free-solution isotachophoresis for separation of human plasma lipoproteins: apolipoprotein and lipid composition of HDL subfractions
by: Alfred Böttcher, et al.
Published: (2000-06-01)

Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease[S]
by: Jan A. Krikken, et al.
Published: (2010-07-01)

The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism
by: Ewa Wieczorek, et al.
Published: (2021-12-01)

Zebrafish as a model for apolipoprotein biology: comprehensive expression analysis and a role for ApoA-IV in regulating food intake
by: Jessica P. Otis, et al.
Published: (2015-03-01)

Protection of cortical cells by equine estrogens against glutamate-induced excitotoxicity is mediated through a calcium independent mechanism
by: Perrella Joel, et al.
Published: (2005-05-01)

Evidence for differential effects of apoE3 and apoE4 on HDL metabolism
by: Paul C.R. Hopkins, et al.
Published: (2002-11-01)

Significance of determining levels of apolipoproteins A-I and B in the diagnostics and assessment of lipid-related atherogenic risk in hyperalpha-lipoproteinemia, hypocholesterolemia and hypo-HDL-chol
by: Kojić-Damjanov Sunčica, et al.
Published: (2007-01-01)

Association between clinical symptoms and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia
by: Wenwang Rao, et al.
Published: (2021-12-01)

Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release
by: Zhang YueMei, et al.
Published: (2005-02-01)

Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis
by: Juraj Koska, et al.
Published: (2022-09-01)

Peptide model of a highly conserved, N-terminal domain of apolipoprotein E is able to modulate lipoprotein binding to a member of the class A scavenger receptor family
by: Samuel R. Dominguez, et al.
Published: (1999-04-01)

Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan
by: Alma Nurtazina, et al.
Published: (2020-07-01)

CRISPR/dCas9 Transcriptional Activation of Endogenous Apolipoprotein AI and Paraoxonase 1 in Enterocytes Alleviates Endothelial Cell Dysfunction
by: Laura Toma, et al.
Published: (2021-11-01)

Electroacupuncture reactivates estrogen receptors to restore the neuroprotective effect of estrogen against cerebral ischemic stroke in long‐term ovariectomized rats
by: Yulong Ma, et al.
Published: (2021-10-01)

Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels
by: Alexandra Schlenck, et al.
Published: (1999-11-01)